Bindu Goyal
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, Amino Acid Enzymes and Metabolism, RNA modifications and cancer, Synthesis of heterocyclic compounds
Most-Cited Works
- → Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer(2014)1,045 cited
- → Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV(2021)81 cited
- → Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition(2012)66 cited
- → Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3(2006)40 cited
- → Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors(2005)39 cited
- → New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases(2007)38 cited
- → One-pot Syntheses of 5-Oxo-1,4,5,6,7,8-hexahydroquinolines and Pyrimido[4,5-b]quinolines using Microwave Irradiation and Ultrasound(1997)31 cited
- → A Facile Synthesis of Pyrazolo[3,4-b]pyridines(1996)30 cited
- → Discovery and Preclinical Evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic Acid, (3S)-3-Morpholinylmethyl Ester (BMS-599626), a Selective and Orally Efficacious Inhibitor of Human Epidermal Growth Factor Receptor 1 and 2 Kinases(2009)30 cited
- → Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): Kinase profiling guided optimization of a 1,2,3-benzotriazole lead(2012)27 cited